{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:37:01Z","timestamp":1793421421575,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-19369-w","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T09:22:46Z","timestamp":1760088166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Knowledge, attitudes, and practices toward fatty liver disease in patients with hepatitis B combined fatty liver disease"],"prefix":"10.1038","volume":"15","clinical-trial-number":[{"clinical-trial-number":"chictr2400095024","registry":"10.18810\/chictr"}],"author":[{"given":"Qian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijian","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maolan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"19369_CR1","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 67, 1560\u20131599 (2018).","journal-title":"Hepatology"},{"key":"19369_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/hep.26110","volume":"58","author":"JL Szpakowski","year":"2013","unstructured":"Szpakowski, J. L. & Tucker, L. Y. Causes of death in patients with hepatitis B: a natural history cohort study in the united States. Hepatology 58, 21\u201330 (2013).","journal-title":"Hepatology"},{"key":"19369_CR3","first-page":"2053","volume":"384","author":"C Trepo","year":"2014","unstructured":"Trepo, C., Chan, H. L., Lok, A. & Hepatitis B Virus Infect. Lancet 384, 2053\u20132063 (2014).","journal-title":"B Virus Infect. Lancet"},{"key":"19369_CR4","doi-asserted-by":"publisher","first-page":"101133","DOI":"10.1016\/j.aohep.2023.101133","volume":"29","author":"ME Rinella","year":"2024","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Ann. Hepatol. 29, 101133 (2024).","journal-title":"Ann. Hepatol."},{"key":"19369_CR5","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.2147\/DMSO.S316096","volume":"14","author":"J Huang","year":"2021","unstructured":"Huang, J. et al. MAFLD criteria May overlook a subtype of patient with steatohepatitis and significant fibrosis. Diabetes Metab. Syndr. Obes. 14, 3417\u20133425 (2021).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"19369_CR6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3350\/cmh.2022.0422","volume":"29","author":"SC Huang","year":"2023","unstructured":"Huang, S. C. & Liu, C. J. Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: challenges and perspectives. Clin. Mol. Hepatol. 29, 320\u2013331 (2023).","journal-title":"Clin. Mol. Hepatol."},{"key":"19369_CR7","doi-asserted-by":"crossref","unstructured":"Hong, S. et al. Prevalence and risk factors of significant fibrosis in CHB patients with concurrent MASLD. Ann. Hepatol. 101589 (2024).","DOI":"10.1016\/j.aohep.2024.101589"},{"key":"19369_CR8","doi-asserted-by":"publisher","first-page":"100836","DOI":"10.1016\/j.jhepr.2023.100836","volume":"5","author":"YM Cheng","year":"2023","unstructured":"Cheng, Y. M., Hsieh, T. H., Wang, C. C. & Kao, J. H. Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease. JHEP Rep. 5, 100836 (2023).","journal-title":"JHEP Rep."},{"key":"19369_CR9","doi-asserted-by":"crossref","unstructured":"Liou, W. L. & Kumar, R. Non-alcoholic fatty liver disease and chronic hepatitis B: friends, foes or strangers. Digestive Med. Research 4, (2021).","DOI":"10.21037\/dmr-21-28"},{"key":"19369_CR10","doi-asserted-by":"publisher","first-page":"100350","DOI":"10.1016\/j.jhepr.2021.100350","volume":"3","author":"LA van Kleef","year":"2021","unstructured":"van Kleef, L. A. et al. Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B. JHEP Rep. 3, 100350 (2021).","journal-title":"JHEP Rep."},{"key":"19369_CR11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"F Tacke","year":"2024","unstructured":"Tacke, F. et al. EASL\u2013EASD\u2013EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J. Hepatol. 81, 492\u2013542 (2024).","journal-title":"J. Hepatol."},{"key":"19369_CR12","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77, 1797\u20131835 (2023).","journal-title":"Hepatology"},{"key":"19369_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s43066-023-00282-8","volume":"13","author":"A Attia","year":"2023","unstructured":"Attia, A., Labib, N. A., Abdelzaher, N. E. E., Musa, S. & Atef, M. Lifestyle determinants as predictor of severity of metabolic associated fatty liver disease (MAFLD). Egypt. Liver J. 13, 47 (2023).","journal-title":"Egypt. Liver J."},{"key":"19369_CR14","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s12072-024-10663-9","volume":"18","author":"SE Keating","year":"2024","unstructured":"Keating, S. E., Chawla, Y., De, A. & George, E. S. Lifestyle intervention for metabolic dysfunction-associated fatty liver disease: a 24-h integrated behavior perspective. Hepatol. Int. 18, 959\u2013976 (2024).","journal-title":"Hepatol. Int."},{"key":"19369_CR15","doi-asserted-by":"publisher","first-page":"103382","DOI":"10.1016\/j.ijnurstu.2019.06.013","volume":"116","author":"LN Kong","year":"2021","unstructured":"Kong, L. N. et al. Self-management behaviors in adults with chronic hepatitis B: A structural equation model. Int. J. Nurs. Stud. 116, 103382 (2021).","journal-title":"Int. J. Nurs. Stud."},{"key":"19369_CR16","doi-asserted-by":"crossref","unstructured":"Ma, G. X. et al. Examining the influencing factors of chronic hepatitis B monitoring behaviors among Asian americans: application of the information-motivation-behavioral model. Int J. Environ. Res. Public. Health 19, (2022).","DOI":"10.3390\/ijerph19084642"},{"key":"19369_CR17","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1177\/0253717620946111","volume":"42","author":"C Andrade","year":"2020","unstructured":"Andrade, C., Menon, V., Ameen, S. & Kumar Praharaj, S. Designing and conducting knowledge, attitude, and practice surveys in psychiatry: practical guidance. Indian J. Psychol. Med. 42, 478\u2013481 (2020).","journal-title":"Indian J. Psychol. Med."},{"key":"19369_CR18","unstructured":"World Health Organization. Advocacy, communication and social mobilization for TB control: a guide to developing knowledge, attitude and practice surveys. http:\/\/whqlibdoc.who.int\/publications\/2008\/9789241596176_eng.pdf. Accessed November 22, 20222008."},{"key":"19369_CR19","first-page":"e66837","volume":"16","author":"AM Someili","year":"2024","unstructured":"Someili, A. M. et al. Knowledge, attitudes, and determinants of nonalcoholic fatty liver disease among adults in Jazan province: A cross-sectional study. Cureus 16, e66837 (2024).","journal-title":"Cureus"},{"key":"19369_CR20","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1097\/MEG.0000000000002548","volume":"35","author":"R Mohamed","year":"2023","unstructured":"Mohamed, R., Yip, C. & Singh, S. Understanding the knowledge, awareness, and attitudes of the public towards liver diseases in Malaysia. Eur. J. Gastroenterol. Hepatol. 35, 742\u2013752 (2023).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"19369_CR21","first-page":"1425","volume":"11","author":"H You","year":"2023","unstructured":"You, H. et al. Guidelines for the prevention and treatment of chronic hepatitis B (version 2022). J. Clin. Transl Hepatol. 11, 1425\u20131442 (2023).","journal-title":"J. Clin. Transl Hepatol."},{"key":"19369_CR22","first-page":"418","volume":"32","author":"Chinese Society of Hepatology CMA","year":"2024","unstructured":"Chinese Society of Hepatology CMA. [Guidelines for the prevention and treatment of metabolic dysfunction-associated (non-alcoholic) fatty liver disease (Version 2024)]. Zhonghua Gan Zang. Bing Za Zhi. 32, 418\u2013434 (2024).","journal-title":"Bing Za Zhi"},{"key":"19369_CR23","first-page":"7","volume":"4","author":"K Kaliyaperumal","year":"2004","unstructured":"Kaliyaperumal, K. Guideline for conducting a knowledge, attitude and practice. AECS Illumination. 4, 7\u20139 (2004).","journal-title":"AECS Illumination"},{"key":"19369_CR24","doi-asserted-by":"crossref","unstructured":"Sitotaw, B. & Philipos, W. Knowledge, attitude, and practices (KAP) on antibiotic use and disposal ways in sidama region, Ethiopia: a community-based cross-sectional survey. Sci. World J.. 8774634 (2023). (2023).","DOI":"10.1155\/2023\/8774634"},{"key":"19369_CR25","unstructured":"Cochran, W. G. Sampling Techniques 3rd edn (Wiley, 1977)."},{"key":"19369_CR26","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1186\/s12889-020-08804-4","volume":"20","author":"L Liu","year":"2020","unstructured":"Liu, L., Qian, X., Chen, Z. & He, T. Health literacy and its effect on chronic disease prevention: evidence from china\u2019s data. BMC Public. Health. 20, 690 (2020).","journal-title":"BMC Public. Health"},{"key":"19369_CR27","doi-asserted-by":"publisher","first-page":"e12891","DOI":"10.2196\/12891","volume":"21","author":"X Lu","year":"2019","unstructured":"Lu, X. & Zhang, R. Impact of Physician-Patient communication in online health communities on patient compliance: Cross-Sectional questionnaire study. J. Med. Internet Res. 21, e12891 (2019).","journal-title":"J. Med. Internet Res."},{"key":"19369_CR28","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12889-023-15152-6","volume":"23","author":"S Botwright","year":"2023","unstructured":"Botwright, S. et al. Which interventions for alcohol use should be included in a universal healthcare benefit package? An umbrella review of targeted interventions to address harmful drinking and dependence. BMC Public. Health. 23, 382 (2023).","journal-title":"BMC Public. Health"},{"key":"19369_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41572-022-00346-w","volume":"8","author":"B Le Foll","year":"2022","unstructured":"Le Foll, B. et al. Tobacco and nicotine use. Nat. Rev. Dis. Primers. 8, 19 (2022).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"19369_CR30","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/1559827618812395","volume":"13","author":"JM Rippe","year":"2019","unstructured":"Rippe, J. M. Lifestyle strategies for risk factor reduction, prevention, and treatment of cardiovascular disease. Am. J. Lifestyle Med. 13, 204\u2013212 (2019).","journal-title":"Am. J. Lifestyle Med."},{"key":"19369_CR31","doi-asserted-by":"crossref","unstructured":"Wei, Y. et al. Health literacy and exercise interventions on clinical outcomes in Chinese patients with diabetes: a propensity score-matched comparison. BMJ Open. Diabetes Res. Care 8, (2020).","DOI":"10.1136\/bmjdrc-2020-001179"},{"key":"19369_CR32","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1186\/s12889-018-5972-x","volume":"18","author":"J-Z Yeh","year":"2018","unstructured":"Yeh, J-Z. et al. Disease-specific health literacy, disease knowledge, and adherence behavior among patients with type 2 diabetes in Taiwan. BMC Public. Health. 18, 1062 (2018).","journal-title":"BMC Public. Health"},{"key":"19369_CR33","unstructured":"Kline, R. B. Principles and practice of structural equation modeling (Fifth Edition) (The Guilford Press, 2023)."},{"key":"19369_CR34","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1177\/1049732319889354","volume":"30","author":"N Bergen","year":"2020","unstructured":"Bergen, N. & Labonte, R. Everything is perfect, and we have no problems: detecting and limiting social desirability bias in qualitative research. Qual. Health Res. 30, 783\u2013792 (2020).","journal-title":"Qual. Health Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19369-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19369-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19369-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T09:22:50Z","timestamp":1760088170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19369-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["19369"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-19369-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ethics Committee of First Affiliated Hospital, Army Medical University, PLA [No:(A) KY2024162]. All participants were informed about the study protocol and provided written informed consent to participate in the study. I confirm that all methods were performed in accordance with the relevant guidelines. All procedures were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"35448"}}